癌症缓解症的机制和有针对性的治疗策略
1Zhejiang Cancer Hospital, Hangzhou, Zhejiang 310022, China; Hangzhou Institute of Medicine (HIM), Chinese Academy of Sciences, Hangzhou, Zhejiang 310018, China; The Second School of Clinical Medicine, Wenzhou Medical University, No. 109 Xueyuan West Road, Wenzhou 325027, Zhejiang, China.
癌症缓解症会导致严重的体重减轻和厌食症,影响20%的患者. 了解其分子机制对于开发有效的治疗方法来对抗这种复杂的综合征至关重要.
科学领域:
- 在瘤学瘤学.
- 代谢综合征是代谢综合征的一种.
- 分子生物学分子生物学
背景情况:
- 瘤缓解症是一种复杂的综合征,在癌症患者中引起厌食症和严重体重减轻.
- 它影响大约20%的癌症患者,显著影响预后.
- 了解白血病的发病因子对于改善治疗结果至关重要.
研究的目的:
- 审查癌症缓解症背后的分子机制.
- 讨论当前治疗策略来管理缓解症.
- 为未来的研究方向提供信息,以改善治疗方法.
主要方法:
- 关于分子机制的文献综述.
- 分析卡赫克西亚的能量失衡.
- 检查厌食症,脂肪组织和骨肌肉缩的驱动因素.
主要成果:
- 厌食症是由瘤因素和影响食欲调节的荷尔蒙干扰驱动的.
- 脂肪组织缩包括增强的脂解和通过白色脂肪组织色增加的能量消耗.
- 骨肌肉缩是由于蛋白质循环失调和线粒体功能障碍造成的,化学疗法加剧了这种情况.
结论:
- 癌症缓解症涉及影响食欲,脂肪代谢和肌肉完整性的复杂分子通路.
- 目前正在探索针对这些机制的治疗策略.
- 需要进一步的研究,以开发更有效的癌症缓存症治疗方法.
更多相关视频
08:02Isolation of Primary Cancer-Associated Fibroblasts from a Syngeneic Murine Model of Breast Cancer for the Study of Targeted Nanoparticles
Published on: May 14, 2021
06:32Intra-Cardiac Injection of Human Prostate Cancer Cells to Create a Bone Metastasis Xenograft Mouse Model
Published on: November 4, 2022
相关概念视频
Targeted Cancer Therapies
There are several types of targeted therapies against...
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The Tumor Microenvironment
Tumor Immunotherapy
